KevinMD May 9, 2024
Harvey Castro, MD, MBA

AlphaFold Three is a monumental leap forward in biomedical research and drug discovery, signaling a new era where artificial intelligence (AI) merges seamlessly with molecular biology to unlock mysteries that have long eluded scientists. Developed by Google DeepMind and Isomorphic Labs, AlphaFold 3 is not just an upgrade to its predecessors; it’s a transformative tool that extends the boundaries of what we can understand and achieve in medicine.

Unprecedented accuracy in molecular predictions

AlphaFold 3 builds on the foundation laid by AlphaFold 2, which was already a game-changer in predicting protein structures. However, AlphaFold 3 goes beyond proteins to encompass the entire spectrum of life’s molecules—including DNA, RNA, ligands, and more. This comprehensive approach allows for a 50% improvement in...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Biotechnology, Pharma / Biotech, Technology
UK Wants More Transparency Into AI Models
OpenAI Bosses: We Take Safety ‘Very Seriously’
Microsoft set to unveil its vision for AI PCs at Build developer conference
Mastering prompt engineering to elevate AI in clinical practice
AI-Guidance Boosts Arrhythmia Ablation Success in Persistent Cases

Share This Article